4-(5-Bromothiophen-2-yl)thiazol-2-ylamine, 95.0%, 5g

1,3-DIHYDRO-5-HYDROXY-1-METHYL-2H-INDOL-2-ONE, 95.0%, 2g

4-(4-chloro-2,8-dimethylquinolin-3-yl)butan-2-one, 95.0%, 5g

1-Oxaspiro[4.5]decan-2-one, 97%, 100mg

5-Bromo-3-fluoro-2-(trifluoromethoxy)pyridine, 97.0%, 1g

1-(3-Fluoro-2-methylphenyl)prop-2-en-1-one, ��97.0%, 100mg

N-(3-Fluorophenyl)pivalamide, 95.0%, 25g

2-Bromo-5-methyl-3-nitro-thiophene, 97.0%, 100mg

GC capillary column ROTI®Cap-1701, 50 m, 0.25 mm, 0.25 µm, 1 Piece(s)

2,6-Dimethylpyridine 4-methylbenzenesulfonate, 95%, 250mg

3-iso-Propylbenzaldehyde, 95.0%, 1g

2-(Methoxymethyl)pyrrolidine hydrochloride, 98%, 1g

(2R,3S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-hydroxybutanoic acid hydrate, 95.0%, 25g